dexamethasone 21-phosphate has been researched along with Necrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunya, VY; Dunn, JP; Gritz, DC; Huang, J; Kempen, JH; Maguire, MG; McWilliams, K; O'Neil, EC; Perez, VL; Peskin, E; Suhler, EB; Ying, GS | 1 |
Foreman, NK; Liu, AK; Macy, ME | 1 |
2 other study(ies) available for dexamethasone 21-phosphate and Necrosis
Article | Year |
---|---|
Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.
Topics: Anterior Eye Segment; Dexamethasone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Delivery Systems; Eye Infections; Female; Glucocorticoids; Humans; Iontophoresis; Male; Middle Aged; Necrosis; Randomized Controlled Trials as Topic; Scleritis; Treatment Outcome | 2018 |
Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Brain; Brain Neoplasms; Child; Dexamethasone; Fatal Outcome; Female; Glioma; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Necrosis; Pons; Quality of Life; Radiation Injuries; Radiosurgery; Treatment Outcome; Vascular Endothelial Growth Factor A | 2009 |